The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcoma.
Immune tolerance
Immunotherapy
Osteosarcoma
Tumour microenvironment
Journal
Cellular immunology
ISSN: 1090-2163
Titre abrégé: Cell Immunol
Pays: Netherlands
ID NLM: 1246405
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
15
09
2017
revised:
22
10
2017
accepted:
26
10
2017
pubmed:
10
11
2017
medline:
12
5
2020
entrez:
10
11
2017
Statut:
ppublish
Résumé
Osteosarcoma is a rare primary bone cancer characterized by cancer cells producing calcified osteoid extracellular matrix and inducing lung metastases with a high frequency. The local microenvironment defined several tumor niches controlling the tumor growth and cell extravasation. The immune infiltrate composes one of these niches. The immune environment of osteosarcoma is mainly composed by T-lymphocytes and macrophages but also contains other subpopulations including B-lymphocytes and mast cells. Osteosarcoma cells control the recruitment and differentiation of immune infiltrating cells and establish a local immune tolerant environment favorable to the tumor growth, drug resistance and the occurrence of metastases. Osteosarcoma cells are able to affect the balance between M1 and M2 macrophage subtypes and so could control the T-lymphocyte responses via the PD-1/PDL-1 system. In addition, mesenchymal stem cells may also contribute to this immune tolerance and strengthen the immune evasion. The present review gives a brief overview of the immune components of osteosarcoma and their most recent therapeutic interests.
Identifiants
pubmed: 29117898
pii: S0008-8749(17)30189-2
doi: 10.1016/j.cellimm.2017.10.011
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
103711Informations de copyright
Copyright © 2017. Published by Elsevier Inc.